V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20198126 | 20134722 | 1.8 | 52.5 | Palliative (P) | 2020-08-26 | 2020-09-11 | BCG Intravesical | 02 | N | TRASTUZUMAB EMTANSINE | 100341536 |
| 20198192 | 20134723 | 1.65 | 82.4 | Adjuvant (A) | 2019-08-20 | 2019-08-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | RADIUM 223 | 100980667 |
| 20198502 | 20134724 | 1.61 | 79 | null | 2018-02-05 | 2018-04-07 | Olaparib | N | N | COSMIC TRIAL | 100826449 |
| 20198855 | 20134726 | 1.61 | 0 | Neo-adjuvant (N) | 2019-12-19 | 2019-12-21 | Atezolizumab | 02 | N | CAPECITABINE + CETUXIMAB | 100140075 |
| 20198916 | 20134727 | 1.75 | 96 | null | 2019-06-07 | 2020-02-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 100498854 |
| 20199059 | 20134728 | 1.82 | 63.7 | Palliative (P) | 2020-02-06 | 2021-01-17 | EOF | N | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 101478725 |
| 20199648 | 20134730 | 1.79 | 63.7 | Curative (C) | 2018-12-15 | 2018-12-19 | CAV | 01 | null | DOCETAXEL + GEMCITABINE | 100122884 |
| 20199729 | 20134731 | 1.83 | 65.8 | Palliative (P) | 2020-04-30 | 2020-05-07 | SCOPE 2 TRIAL | 02 | N | GEMCITABINE + OXALIPLATIN | 100995507 |
| 20199788 | 20134732 | 1.52 | 71.5 | Curative (C) | 2017-11-04 | 2017-11-10 | Paclitaxel albumin (Abraxane) 7 day | 01 | Y | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100208745 |
| 20199813 | 20134733 | 1.69 | 58 | null | 2017-07-12 | 2017-07-17 | COSMIC TRIAL | 02 | N | CAPECITABINE + CISPLATIN + MITOMYCIN | 100408320 |
| 20200205 | 20134734 | 1.75 | 77.9 | null | 2018-04-01 | 2018-04-09 | CTD Attenuated (Thalidomide 50mg) | 02 | N | LETROZOLE + PALBOCICLIB | 100355560 |
| 20200367 | 20134735 | 1.78 | 144.7 | null | 2016-07-03 | 2016-07-26 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101569823 |
| 20200379 | 20134736 | 1.6 | 61 | 03 | 2020-01-14 | 2020-01-22 | PACLITAXEL + RAMUCIRUMAB | 02 | N | CAPITAL TRIAL | 101544874 |
| 20200450 | 20134737 | null | null | Palliative (P) | 2019-02-16 | 2019-03-08 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101451940 |
| 20200777 | 20134738 | 1.75 | 56.8 | Palliative (P) | 2011-07-12 | 2018-08-02 | ANAGRELIDE | 2 | N | ECARBOX | 100973365 |
| 20200806 | 20134739 | 1.72 | 62.6 | null | 2019-03-31 | 2019-04-12 | CHOP R | 02 | null | GO2 TRIAL | 101281774 |
| 20200823 | 20134740 | 1.75 | null | null | 2018-08-08 | 2018-09-06 | POMALIDOMIDE | 01 | null | DOXORUBICIN | 100337471 |
| 20201166 | 20134741 | 1.87 | 76.2 | Palliative (P) | 2018-06-25 | 2018-07-13 | null | 01 | N | POMALIDOMIDE | 100687744 |
| 20201314 | 20134742 | 1.58 | 112.45 | null | 2018-09-18 | 2018-10-02 | Cisplatin + Docetaxel | N | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101256435 |
| 20201351 | 20134743 | 1.54 | 89 | null | null | 2020-01-20 | CARBOPLATIN + VINORELBINE | N | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100065020 |
| 20201447 | 20134744 | 1.56 | 44.9 | null | 2018-07-03 | 2018-07-22 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | CAM-PLEX TRIAL | 101634245 |
| 20201451 | 20134745 | 1.77 | 81 | null | 2021-08-30 | 2021-10-10 | Cisplatin + Pemetrexed | 02 | null | METHOTREXATE | 101639167 |
| 20201521 | 20134746 | 1.46 | 67 | Palliative (P) | 2018-11-06 | 2018-11-21 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 100554145 |
| 20201545 | 20134747 | 1.71 | 70 | Palliative (P) | 2020-10-30 | 2020-11-19 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | HYDROXYCARBAMIDE | 100831795 |
| 20201595 | 20134748 | 1.72 | 51.9 | Curative (C) | 2020-08-26 | 2020-10-02 | Topotecan (oral) | 02 | null | PEMETREXED | 100669388 |
| 20201779 | 20134749 | 1.75 | 58.2 | Palliative (P) | 2018-06-18 | 2018-07-06 | Capecitabine + Carboplatin + RT | 02 | null | CAPECITABINE + MITOMYCIN + RT | 100372276 |
| 20201824 | 20134750 | 1.62 | 95 | Disease modification (D) | null | 2017-11-05 | GDP | N | null | TOPOTECAN | 100763172 |
| 20201920 | 20134751 | 1.46 | null | Neo-adjuvant (N) | 2017-01-03 | 2017-02-03 | Binimetinib + Encorafenib | 1 | null | FLUOROURACIL + RT | 101584942 |
| 20201996 | 20134752 | 1.84 | 80.2 | Curative (C) | null | 2016-01-26 | COSMIC TRIAL | 01 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100489506 |
| 20202307 | 20134755 | 1.59 | 61.9 | null | 2017-03-21 | 2017-03-21 | CAPE + OXALIPLATIN + TRASTUZUMAB | N | Y | PEMETREXED | 100270258 |
| 20202435 | 20134756 | 1.48 | 76.65 | null | 2021-05-13 | 2021-05-22 | ECF | 02 | N | BACILLUS CALMETTE-GUERIN | 101699061 |
| 20202533 | 20134757 | 1.65 | 62.2 | Curative (C) | 2017-05-06 | 2017-05-21 | null | 01 | null | MITOMYCIN | 101795762 |
| 20202543 | 20134758 | 1.69 | 71.4 | Palliative (P) | 2018-01-06 | 2018-01-06 | CISPLATIN + TEYSUNO | 02 | N | ARISTOTLE TRIAL | 100765754 |
| 20202570 | 20134759 | 1.69 | 68 | Curative (C) | 2017-06-11 | 2017-06-15 | Capecitabine+Cisplatin+Streptozocin | 01 | Y | TRABECTEDIN | 100585160 |
| 20202666 | 20134760 | 1.9 | 76.7 | null | 2018-11-14 | 2018-12-17 | ECarboX | 02 | null | ABEMACICLIB + FULVESTRANT | 101544285 |
| 20202716 | 20134761 | 1.75 | null | Curative (C) | 2020-01-10 | 2020-02-28 | Paclitaxel albumin (Abraxane) 21day | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100129577 |
| 20203047 | 20134763 | 1.73 | 59 | Palliative (P) | 2018-11-24 | 2018-11-25 | Capecitabine + Carboplatin + RT | 02 | N | PEMETREXED | 101847148 |
| 20203055 | 20134764 | 1.96 | 95 | Curative (C) | 2018-05-24 | 2018-06-23 | BCG Intravesical | N | null | CISPLATIN + FLUOROURACIL + RT | 100679674 |
| 20203072 | 20134766 | 1.65 | 55.1 | Neo-adjuvant (N) | 2019-06-07 | 2019-06-07 | OSIMERTINIB | 01 | N | CISPLATIN + RT | 100822352 |
| 20203145 | 20134767 | 1.58 | 78 | Adjuvant (A) | 2019-04-25 | 2019-04-28 | ECarboF | 02 | N | FLUOROURACIL + RT | 100097984 |
| 20203204 | 20134768 | 1.56 | 108.9 | Palliative (P) | 2020-09-22 | 2020-09-26 | Rituximab | N | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101602500 |
| 20203300 | 20134769 | 1.51 | 58.65 | null | 2018-03-31 | 2018-04-12 | Rucaparib | 02 | null | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100541899 |
| 20203394 | 20134771 | 1.58 | 80.8 | Palliative (P) | 2018-07-15 | 2018-08-06 | ACTICCA-1 Trial | 02 | N | FLUOROURACIL + OXALIPLATIN + TRASTUZUMAB | 101785749 |
| 20203480 | 20134772 | 1.65 | 58.2 | null | null | 2020-02-03 | null | 02 | N | EOF | 101053316 |
| 20203627 | 20134773 | 1.52 | 75.8 | null | 2021-10-02 | 2021-10-08 | MELPHALAN | 02 | null | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101042890 |
| 20203679 | 20134774 | 1.59 | 82.1 | Palliative (P) | 2019-11-25 | 2019-11-25 | Irinotecan + Raltitrexed | 02 | N | BACILLUS CALMETTE-GUERIN | 101039595 |
| 20203786 | 20134775 | 1.8 | 84.1 | null | 2020-01-28 | 2021-11-03 | CHLVPP | 02 | N | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 100395429 |
| 20203794 | 20134776 | 1.14 | 15.9 | Palliative (P) | 2018-08-16 | 2018-08-23 | EOF | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100679328 |
| 20203839 | 20134777 | 1.57 | 59 | Palliative (P) | 2018-05-30 | 2018-10-27 | Encorafenib | 02 | null | NIRAPARIB | 101501743 |
| 20203844 | 20134778 | 1.79 | 49.6 | Palliative (P) | 2020-11-07 | 2020-11-07 | COSMIC TRIAL | 02 | N | DOCETAXEL + TRASTUZUMAB | 100156914 |